Filter posts

An Insider’s View of the BioGENEius Challenge

By Erica Hiar, Environics A big highlight every year for many attendees at BIO International …

What’s the Buzz?

Meet Deuteria Pharmaceuticals, winner of the 2012 Buzz of BIO competition. What is Buzz of …

BIO 2012 Super Session Recap: Ernst & Young’s Beyond Borders

The fanfare surrounding this morning’s unveiling of Ernst & Young’s 26th annual report on the …

Prior User Rights and Trade Secrets

By Joe Allen, President, Allen and Associates One theme of the day is the cloud …

Recent Developments in Patentability: Prometheus and Myriad

By Joe Allen, President, Allen and Associates Recent Developments in Patentability: Prometheus and Myriad at …

From Bench to Bedside in a Bioeconomy

By Joe Allen, President, Allen and Associates It’s a sign of a well crafted program …

Dr. Lewis Sullivan Leads Panel on Diversity in Education and the Biotech Workplace

This year the Diversity Summit at the 2012 BIO International Convention focused on the importance …

Measuring the Impact of Innovation

By Joe Allen, President, Allen and Associates It’s always an indication of interest and importance …

Biotech Companies are Bringing Innovation to Global Health

By Don Joseph, CEO, BIO Ventures for Global Health In March, we at BIO Ventures …

Out and About in Boston During the BIO International Convention

By Bob Coughlin, President & CEO, MassBio You will surely be very busy during your time …